Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 7, 2019
Previous Article Next Article

Synthesis and initial biological evaluation of myxocoumarin B

Author affiliations

Abstract

The myxocoumarins A and B from Stigmatella aurantiaca MYX-030 are natural products featuring unusual nitro- and long-chain alkyl substitution. While myxocoumarin A was shown to exhibit strong antifungal properties, the antifungal potential of myxocoumarin B was not yet assessed due to low production titers during initial isolation. We therefore developed a total synthesis of myxocoumarin B that involves a late-stage Pd-catalyzed nitration of the coumarin core. The availability of synthetic material facilitated the initial evaluation of the bioactivity of myxocoumarin B, which revealed a lack of activity against medically relevant Candida sp. and low cytotoxicity in vitro against human fibroblasts (MRC-5) and in vivo (zebrafish).

Graphical abstract: Synthesis and initial biological evaluation of myxocoumarin B

Back to tab navigation

Supplementary files

Publication details

The article was received on 13 Sep 2018, accepted on 18 Oct 2018 and first published on 22 Oct 2018


Article type: Paper
DOI: 10.1039/C8OB02273A
Org. Biomol. Chem., 2019,17, 1966-1969

  •   Request permissions

    Synthesis and initial biological evaluation of myxocoumarin B

    J. I. Müller, K. Kusserow, G. Hertrampf, A. Pavic, J. Nikodinovic-Runic and T. A. M. Gulder, Org. Biomol. Chem., 2019, 17, 1966
    DOI: 10.1039/C8OB02273A

Search articles by author

Spotlight

Advertisements